Feedback / Questions
factor VIIa-CTP (OPK88005) - OPKO Health
OPKO: Barrington Research Fall Investment Conference
(OPKO health)
-
Sep 3, 2015 -
Anticipated initiation of P2a trial for hemophilia in Q4 2015
Anticipated new P2a trial
•
Hemophilia
http://files.shareholder.com/downloads/OPKO/665910476x0x848449/881A7DD7-D2A8-4152-B5D7-EE4AAA04573C/OPKO_Health_Barrington_Final.pdf
Sep 3, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.